WASHINGTON,
Nov. 30, 2016 /PRNewswire-USNewswire/ -- A new national survey finds most
voters blame drug companies not only for high drug prices, but also for
out-of-pocket costs. The findings undermine the drug industry's $100 million PR
campaign to blame higher costs on employers, unions, health plans and the
pharmacy benefit managers (PBMs) they use to negotiate discounts on
prescription drugs.
"Consumers
are well aware drug companies set drug prices and they know higher prices mean
higher out-of-pocket costs. No one's buying the drug companies' campaign to
shift blame to employers, unions, plans, or the PBMs that negotiate discounts
on their behalf," said Pharmaceutical Care Management Association (PCMA)
President and CEO Mark Merritt.
North Star
Opinion Research surveyed 1,000 registered voters nationwide.
Key findings
from survey include:
By almost
3-to-1, voters blame high drug prices for increased cost-sharing.
Only 1-in-5
voters buy the drugmakers' "rebates cause high prices" message.
Three-quarters
of voters say the cost of prescription drugs is too high.
More than
4-of-5 voters with prescription drug coverage are satisfied with it.
PCMA is the
national association representing America's pharmacy benefit managers (PBMs).
PBMs administer prescription drug plans for more than 266 million Americans who
have health insurance from a variety of sponsors including: commercial health
plans, self-insured employer plans, union plans, Medicare Part D plans, the
Federal Employees Health Benefits Program (FEHBP), state government employee
plans, managed Medicaid plans, and others.
SOURCE Pharmaceutical Care Management Association
No comments:
Post a Comment